Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

65.42 -3.47 (-5.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 655,933
Open 69.10
Bid (Size) 64.80 (100)
Ask (Size) 67.50 (100)
Prev. Close 68.89
Today's Range 64.80 - 69.55
52wk Range 32.21 - 170.87
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 7, 2026) - Kahn Swick & Foti, LLC ("KSF")... 
Via Newsfile
Topics Fraud Lawsuit
News headline image
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. (WGS)
From Bernstein Liebhard LLP
Via GlobeNewswire

Performance

YTD
-50.6%
-50.6%
1 Month
+26.3%
+26.3%
3 Month
-1.8%
-1.8%
6 Month
-50.3%
-50.3%
1 Year
-23.7%
-23.7%

More News

Read More
News headline image
Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); GeneDx Holdings Corp. (NASDAQ: WGS); Navan, Inc. (NASDAQ: NAVN); and New Era Energy & Digital, Inc. (NASDAQ: NUAI) (FKA New Era Helium (NASDAQ: NEHC)): Grabar Law Office is
From Grabar Law Office
Via GlobeNewswire
News headline image
INVESTOR DEADLINE ALERT: GeneDx Holdings Corp. (WGS) Class Action Lawsuit: Investors Face August 3, 2026, Deadline
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
INVESTOR DEADLINE ALERT: GeneDx Holdings Corp. (WGS) Class Action Lawsuit: Investors Face August 3, 2026, Deadline
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Via Newsfile
Topics Fraud Lawsuit
News headline image
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
INVESTOR DEADLINE ALERT: GeneDx Holdings Corp. (WGS) Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
INVESTOR DEADLINE ALERT: GeneDx Holdings Corp. (WGS) Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
WGS Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages WGS Investors With Losses to Contact the Firm
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
WGS Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages WGS Investors With Losses to Contact the Firm
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Via Newsfile
Topics Fraud Lawsuit
News headline image
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
GeneDx Holdings Corp. Securities Fraud Class Action Lawsuit Filed; August 3, 2026, Lead Plaintiff Deadline
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
GeneDx Holdings Corp. Securities Fraud Class Action Lawsuit Filed; August 3, 2026, Lead Plaintiff Deadline
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Via Newsfile
Topics Fraud Lawsuit
News headline image
GENEDX HOLDINGS CORP. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 3, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of GeneDx Holdings Corp. (NASDAQ: WGS); Navan, Inc. (NASDAQ: NAVN); New Era Energy & Digital, Inc. (NASDAQ: NUAI) (FKA New Era Helium (NASDAQ: NEHC)); and Verra Mobility Corporation (NASDAQ: VRRM): Grabar Law
From Grabar Law Office
Via GlobeNewswire
News headline image
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
GeneDx Holdings Corp. Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
GeneDx Holdings Corp. Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming Deadlines – WGS
From Pomerantz LLP
Via GlobeNewswire
News headline image
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Via Newsfile
Topics Fraud Lawsuit

Frequently Asked Questions

Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?
Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.
What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?
GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?
The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market
What is the current price of GeneDx Holdings Corp. - Class A Common Stock?
The current price of GeneDx Holdings Corp. - Class A Common Stock is 65.42
When was GeneDx Holdings Corp. - Class A Common Stock last traded?
The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 07/07/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.